11 Best Pot Stocks to Buy According to Hedge Funds

Page 3 of 10

8. Cronos Group Inc. (NASDAQ:CRON)

On February 24, TD Securities initiated coverage of Cronos Group Inc. (NASDAQ:CRON) with a Buy rating and C$4.50 price target, citing its portfolio of iconic Canadian cannabis brands and scalable cost structure. The firm believes Cronos is positioned to expand profitability as revenue scales against a lean operating base and advanced cultivation practices.

Previously, on January 27, Canaccord analyst Kenric Tyghe initiated coverage with a Buy rating and C$4.25 price target. While Canada and Israel currently represent Cronos Group Inc. (NASDAQ:CRON)’s largest markets, the analyst views the acquisition of CanAdelaar and the expansion of Cronos Growing Company as foundational to a broader transformation strategy, potentially enhancing vertical integration and international reach.

Founded in 2012 and headquartered in Toronto, Cronos Group Inc. (NASDAQ:CRON) is a cannabinoid company that cultivates, produces, and markets cannabis products globally. It sells a range of products such as dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under its brands such as Spinach, Lord Jones, and PEACE NATURALS. With 19 hedge funds having stakes in the company as of Q3 2025, as recorded by Insider Monkey, Cronos Group is among the best pot stocks to buy according to hedge funds.

Page 3 of 10